Update on management of seminoma | Zendy

Alan Horwich | Zendy; EmmaJ Alexander | Zendy; IngridM White | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Update on management of seminoma

Author(s) -

Alan Horwich,

EmmaJ Alexander,

IngridM White

Publication year - 2010

Publication title -

indian journal of urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.333

H-Index - 30

eISSN - 1998-3824

pISSN - 0970-1591

DOI - 10.4103/0970-1591.60451

Subject(s) - medicine , carboplatin , seminoma , radiation therapy , chemotherapy , disease , adjuvant chemotherapy , oncology , adjuvant , stage (stratigraphy) , intensive care medicine , cisplatin , cancer , paleontology , breast cancer , biology

Testicular germ cell tumors and, in particular, seminomas are exquisitely radiation and chemotherapy-sensitive and most presentations are highly curable. In recent years the management focus has been on reducing late sequelae of treatment. For Stage I disease surveillance and adjuvant carboplatin, chemotherapy has become an option. The efficacy of combination chemotherapy has been established for advanced metastatic disease. Through a review of the available literature this article outlines the recent changes in the management of seminoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research